The first multicenter clinical trial on PTS intrabronchial injection in NSCLC-SMAO.
PTS leads to ameliorated dyspnea, improved lung function and prolonged survival.
PTS intrabronchial injection is an effective palliative therapy for NSCLC-SMAO.
PTS might be particularly suitable for medical institutions in developing countries.